Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Spark Therapeutics buy Quitte

Spark Therapeutics
Start price
€41.29
12.12.17 / 50%
Target price
€50.51
01.02.18
Performance (%)
22.74%
End price
€50.68
01.02.18
Summary
This prediction ended on 01.02.18 with a price of €50.68. The BUY prediction by Quitte finished with a performance of 22.74%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Spark Therapeutics - - - -
iShares Core DAX® 2,49 % -5,94 % 2,90 % 45,72 %
iShares Nasdaq 100 1,65 % -2,46 % 15,75 % 73,26 %
iShares Nikkei 225® 0,55 % -7,60 % 30,35 % 48,77 %
iShares S&P 500 1,35 % -2,94 % 10,34 % 55,80 %

Comments by Quitte for this prediction

In the thread Spark Therapeutics diskutieren
Prediction Buy
Perf. (%) 22.74%
Target price 50.512
Change
Ends at 01.02.18

Lux am Ende des Tunnels

Luxturna hat den Priority Review-Status
der 12. Januar dürfte entscheidend sein


ich denke, es gibt Licht am Ende des Tunnels


Quitte 
0
Report Share
12.12.17
Prediction Buy
Perf. (%) 22.74%
Target price 50.512
Change
Ends at 01.02.18

(Zielkurs erreicht)

Quitte 
0
Report Share
01.02.18